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Abstract
Background: Herpes simplex virus type 1 (HSV-1) can establish both lytic and latent infections in humans. The
phosphorylation of histone H2AX, a common marker of DNA damage, during lytic infection by HSV-1 is well
established. However, the role(s) of H2AX phosphorylation in lytic infection remain unclear.
Methods: Following infection of human foreskin fibroblasts by HSV-1 or HSV-2, we assayed the phosphorylation of
H2AX in the presence of inhibitors of transcription, translation, or viral DNA replication, or in the presence of
inhibitors of ATM and ATR kinases (KU-55933 and VE-821, respectively). We also assayed viral replication in
fibroblasts in the presence of the kinase inhibitors or siRNAs specific for ATM and ATR, as well as in cell lines
deficient for either ATR or ATM.
Results: The expression of viral immediate-early and early proteins (including the viral DNA polymerase), but not
viral DNA replication or late protein expression, were required for H2AX phosphorylation following HSV-1 infection.
Inhibition of ATM kinase activity prevented HSV-stimulated H2AX phosphorylation but had only a minor effect on
DNA replication and virus yield in HFF cells. These results differ from previous reports of a dramatic reduction in
viral yield following chemical inhibition of ATM in oral keratinocytes or following infection of ATM−/− cells.
Inhibition of the closely related kinase ATR (whether by chemical inhibitor or siRNA disruption) had no effect on
H2AX phosphorylation and reduced viral DNA replication only moderately. During infection by HSV-2, H2AX
phosphorylation was similarly dispensable but was dependent on both ATM activity and viral DNA replication.
Conclusion: H2AX phosphorylation represents a cell type-specific and virus type-specific host response to HSV
infection with little impact on viral infection.
Keywords: Herpes simplex virus, DNA damage, H2AX, γH2AX, Ataxia telangiectasia mutated, ATM, ATR, Human
foreskin fibroblast
Background
Herpes simplex virus type 1 (HSV-1) has a double-stranded
DNA genome of approximately 152 kilobasepairs. Like
other herpes viruses, HSV-1 infection is characterized by
two distinct cycles; a productive lytic infection and a non-
productive latent infection. During lytic infection, viral
genes are expressed in a cascade of at least three classes,
commonly designated the immediate-early (IE), early (E),
and late (L) genes. Proteins encoded by IE genes facilitate
expression of E and L genes. The E genes primarily en-
code the viral DNA replication machinery. L genes,
which are sometimes separated into leaky late and true
late genes, encode proteins involved in the structure
and assembly of the virus particle. Viral DNA replica-
tion is required to express true late genes and enhances
leaky late gene expression [1, 2].
The interplay between viral and cellular processes during
HSV replication is complex. The virus can subvert cellular
mechanisms to enhance the infection process; in response,
the cell has many antiviral mechanisms in place to protect
its functions. Histone variant H2AX is one example of the
complex nature of these virus-host interactions. H2AX
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constitutes about 10 % of the total H2A distributed through
the chromatin of a typical cell. The particular functions of
H2AX are still poorly understood, but H2AX is phosphory-
lated in response to DNA damage at sites up to several
kilobasepairs around the site of damage [3]. Disruption of
the mouse H2afx gene encoding H2AX results in genomic
instability and hypersensitivity to radiation [4, 5]. In HSV-1
infection, H2AX is phosphorylated during viral E gene ex-
pression, and the amount of phosphorylated H2AX
(γH2AX) increases as the gene cascade continues [6–8].
This post-translational modification could reflect host re-
sponses attempting to limit the infection process; it could
be beneficial to the virus; or it could be a host response
without meaningful consequences for viral infection.
Incoming linear HSV viral genomes inherently have free
DNA ends that conceivably might initiate a cellular DNA
damage response [9]. But the mere delivery of viral DNA
into the cell is likely insufficient to trigger H2AX phos-
phorylation, because that phosphorylation occurs well
after viral entry [6]. An alternative hypothesis predicts that
the replication or recombination of the viral DNA bearing
single-strand nicks and gaps will initiate a DNA damage
response including H2AX phosphorylation. To date, the
mechanisms of H2AX phosphorylation during HSV infec-
tion and the effects on viral replication remain incom-
pletely defined.
H2AX is a direct substrate for phosphorylation by the
host cell kinases ATM (ataxia telangiectasia mutated)
and ATR (ataxia telangiectasia and Rad3-related), which
along with DNA-PK are the central signaling proteins of
the DNA damage response pathway. ATM and DNA-PK
typically respond to double-strand breaks, whereas ATR
responds to single-strand DNA and stalled replication
forks [10]. The potential roles of these protein kinases in
HSV infection have been investigated [7, 11–17]. Others
have shown that the viral IE protein ICP0 induces
proteasome-mediated degradation of the catalytic
subunit of DNA-PK and that the loss of DNA-PK activ-
ity increases virus replication [12, 18]. The kinase func-
tion of ATM is activated during viral DNA replication
[11, 14, 15], and reduced HSV-1 replication in ATM-
deficient cell lines suggests that ATM is important for
viral replication during lytic infection [11]. Li et al. [6]
and Alekseev et al. [19] also found that an inhibitor spe-
cific for ATM (KU-55933) resulted in a decrease of
HSV-1 at low multiplicity of infection (MOI) in AD-293
and OKF9 cells, respectively. In contrast, Shirata et al.
[14] reported that knockdown of ATM had no effect on
HSV-2 infection in 293 T cells. This difference in ATM
dependence between HSV-1 and HSV-2 is curious. In
addition, we do not yet know the trigger responsible for
H2AX phosphorylation during HSV infection nor, more
importantly, whether γH2AX plays an active role in pro-
duction of HSV.
We report here that ATM activity (but not ATR activ-
ity) and the expression of viral proteins (including UL30,
the viral DNA polymerase), but not viral DNA replica-
tion per se, are necessary for HSV-1-induced H2AX
phosphorylation in human foreskin fibroblasts. Intri-
guingly, during infection of fibroblasts by HSV-2, H2AX
phosphorylation does require viral DNA replication.
However, reducing H2AX phosphorylation by chemical
or siRNA inhibition of ATM did not significantly affect
HSV-1 or HSV-2 DNA replication and virus production
at high MOI, and had only a modest effect at lower
MOI. These results differ from reports [6, 19] which
suggest that ATM performs an important role in HSV-1
infection of other cell lines. Collectively, these observa-
tions suggest that H2AX phosphorylation represents a
cell-specific and virus-specific host response to HSV in-




Vero cells were obtained from ATCC and telomerase-
transformed human foreskin fibroblasts (HFFs) were
provided by Wade Bresnahan [20]. Vero and HFF cells
were maintained in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 10 % fetal bovine serum
(FBS). Vero-PolB3 cells [21] a gift from Dr. Don Coen,
are stably transformed with the viral UL30 gene and ex-
press the viral DNA polymerase from its native pro-
moter. These cells were maintained in DMEM with 10
% FBS and 400 μg/ml G418. The primary human skin
fibroblast cell lines GM01588A and GM02052F (ATM−/−
cell lines each with a point mutation resulting in early
termination of ATM [22]), GM18366D (expressing low
levels of ATR due to a point mutation resulting in alter-
nate splicing [23]), and GM05757B (expressing wild-
type ATM and ATR) were obtained from Coriell
Institute (Camden, NJ). GM01588A, GM02052F, and
GM05757B cells were maintained in DMEM plus 10 %
FBS; GM18366D cells were maintained in DMEM plus
20 % FBS. HSV-1 virus strain KOS and HSV-2 virus
strain G were propagated and titered in Vero cells.
HSV-1 strains HP66 and ΔS1, both bearing deletions of
the viral DNA polymerase gene UL30, were obtained
from Dr. Coen and were grown and titered in Vero-
PolB3 cells [21].
Reagents
Antibodies against H2AX (ABCM-AB10475) and phos-
phorylated H2AX (γH2AX) (ABCM-AB4178) were pur-
chased from Abcam. UL30 antibody was a gift from Dr.
Nigel Stow [24]. GAPDH and actin antibodies were ob-
tained from Millipore (MAB374 and MAB1501). The siR-
NAs were purchased from QIAGEN, including control
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siRNAs (SI03650318 and SI04381048) and validated siR-
NAs directed against ATM (ATM1= SI00299299 and
ATM2= SI00604730) or ATR (ATR1 = SI02660231 and
ATR2 = SI02664347). A third siRNA directed against
ATR, here designated ATR3, is identical in sequence to an
shRNA used by Dr. Sandra Weller and colleagues [13, 17].
Transfections were done with SiLentFect (BioRad). Kinase
inhibitors KU-55933 [25] and CGK733 [26–29] were pur-
chased from EMD (118500 and 118501). VE-821 [30] was
purchased from AdooQ Bioscience (A11605). Actinomy-
cin D (A9415), cycloheximide (C7698), phosphonoacetic
acid (PAA) (284270) and doxorubicin (D1515) were pur-
chased from Sigma. The 2X PhosphoStop phosphatase
inhibitor cocktail and 2X minicomplete protease inhibitor
cocktail (04906845001 and 11836153001) were both pur-
chased from Roche. TRIzol (15596–026) was purchased
from Invitrogen. Reverse transcription reactions were per-
formed with a High Capacity cDNA Reverse Transcription
Kit (ABI). SYBR Green master mix (04673522001) was
purchased from Roche. CellTiter-Glo viability kit was pur-
chased from Promega (G7570).
Gene expression and quantitative PCR
Total RNA was purified from cells using TRIzol reagent
or the Qiagen RNeasy kit and was reverse-transcribed
with random primers and RNAseOut according to the
manufacturer’s protocol. Gene expression was quantified
by real-time quantitative PCR (qPCR) using primers spe-
cific for the selected viral or human genes. DNA samples
were collected using Qiagen DNeasy Blood and Tissue
Kit and were quantified by qPCR with primers specific
for viral ICP4 or ICP0 genes or the human 18S riboso-
mal RNA gene. The qPCR was performed on an ABI
7500 RT-PCR system (Applied Biosystems) using SYBR
Green master mix; relative DNA or RNA levels were an-
alyzed by the 2–ΔΔCt method.
HSV infection
HSV-1 and HSV-2 infections in HFF cells were per-
formed as follows. Cells were washed with DMEM,
inoculated with the appropriate MOI, and incubated at
37 °C. At 1 h post-infection (h p.i.) the inoculum was as-
pirated and cells were washed with DMEM. Cells were
incubated in DMEM containing 10 % serum at 37 °C
and were harvested at various times. In kinase inhibitor
experiments, KU-55933, VE-821, or CGK733 (or DMSO
vehicle) was added to cell culture wells at 1 h p.i. in nor-
mal media. For inhibition of viral DNA replication, PAA
was added at 1 h p.i. to the normal medium to a final
concentration of 400 μg/ml. For infections using actino-
mycin D (1 μg/ml) or cycloheximide (100 μg/ml), the in-
hibitors were added to the cells for 1 h before infection
and were present during the entire course of infection.
Infections for plaque assays were performed as de-
scribed above, except that DMEM with 2 % FBS and 0.9 %
SeaPlaque agarose was added to the infected cells at 1 h
p.i. At 3 d p.i. the cells were stained with neutral red for
2 h at 37 °C to visualize plaques.
Western blot
Lysates analyzed by western blot were collected as fol-
lows. After the cell culture medium was aspirated, the
cells were washed with phosphate-buffered saline (PBS)
and were lysed directly in 2X SDS-PAGE loading buffer
containing 2X PhosphoStop phophatase inhibitor cock-
tail and 2X minicomplete protease inhibitor cocktail
with 5 % β-mercaptoethanol. The lysates were heated at
95 °F for 5 min and separated on 4-20 % polyacrylamide
gels. The proteins were transferred to polyvinylidene
fluoride membranes and blocked in 1X TTBS (100 mM
Tris, pH 7.5, 150 mM NaCl, 0.1 % Tween 20) containing
2 % or 5 % (w/v) bovine serum albumin. The blocked
membrane was incubated with primary antibody over-
night at 4 °C at the dilution suggested by the supplier.
The membrane was washed with TTBS and incubated
with the appropriate secondary antibody conjugated with
horseradish peroxidase at 5000-fold dilution for 1 h at
room temperature. The membrane was again washed
and the horseradish peroxidase was detected by
chemiluminescence.
siRNA transfections
siRNA transfections of HFF cells were performed using
the transfection reagent SilentFect according to the
manufacturer’s protocol, with a final siRNA concentra-
tion of 16.7 nM. At 24 h post-transfection, the transfec-
tion mixture was aspirated and replaced with medium
containing DMEM plus 10 % FBS. Cells were incubated
at 37 °C for approximately 72 h post-transfection. Cells
either were harvested for analysis of the knockdown effi-
ciency or were infected with HSV using the infection
protocol described above. Total RNA and DNA were
collected at 16 h p.i. and the amount of viral RNA or
DNA was measured by qPCR and normalized to host
18S DNA and negative control siRNA samples.
Nuclei extraction by gradient centrifugation
ATR-deficient and HFF cells were infected as detailed
above. At 2 h p.i., cells were trypsinized, resuspended in
10 % FBS DMEM, and counted to ensure equal numbers
of cells were loaded into each gradient. Gradients were
prepared and centrifuged as described previously [31],
except that Optiprep media (Sigma) was used as the gra-
dient material and dilutions were modified accordingly
to obtain the correct percentage of iodixanol for each
layer. Nuclear and cytoplasmic fractions were harvested
and tested for purity by qPCR with GAPDH and 18S
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primers, as well as by immunoblotting with GAPDH and
histone 3.3 antibodies. DNA in infected samples was
quantified by qPCR with ICP0 and 18S rRNA primers.
Results
H2AX phosphorylation during infection by HSV-2 (but not
HSV-1) requires viral DNA synthesis
A number of viruses including HSV induce the host
DNA damage response pathway and subsequent phos-
phorylation of histone H2AX [6, 7]. However, the mech-
anism that triggers this pathway and its importance for
viral replication during HSV infection still remains un-
clear. To explore this, we first verified that HSV-1 was
sufficient to initiate γH2AX formation in telomerase-
transformed human foreskin fibroblasts (HFF). HFF cells
were infected with HSV-1 at high multiplicity (MOI 5),
and lysates from several time points post-infection were
collected for immunoblotting using an antibody that de-
tects γH2AX. γH2AX was faintly detectable at 4 h post-
infection (h p.i.) and levels of γH2AX increased during
the course of infection (Fig. 1a). This pattern of γH2AX
induction well after the start of infection indicates that
the phosphorylation is unlikely to be induced simply by
entry of virion DNA.
To more precisely determine the requirements for in-
ducing γH2AX, we used actinomycin D to interrupt
mRNA synthesis, cycloheximide to inhibit translation, or
phosphonoacetic acid (PAA) to disrupt viral DNA repli-
cation. HFF cells infected with HSV-1 in the presence of
either actinomycin D or cycloheximide showed inhib-
ition of H2AX phosphorylation (Fig. 1b). We conclude
that de novo synthesis of one or more proteins in the in-
fected cell is required to trigger H2AX phosphorylation.
As a control, we tested whether de novo protein synthe-
sis is always necessary for ATM-mediated H2AX phos-
phorylation. When doxorubicin was used to induce
double-stranded DNA breaks, neither actinomycin D
nor cycloheximide inhibited γH2AX formation (Fig. 1b,
right panel), indicating that transcription and translation
are not inherently required for H2AX phosphorylation
in fibroblasts. Additionally, although the presence of
PAA during a HSV-1 infection potently inhibited viral
DNA replication and thus late protein (VP16) synthesis
(Fig. 1c), the presence of PAA did not inhibit H2AX
phosphorylation during HSV-1 infection (Fig. 1b and c).
This result indicates that neither viral DNA replication
nor true late proteins are required for induction of
γH2AX in HSV-1 infection.
Fig. 1 HSV-induced H2AX phosphorylation requires the presence of the viral polymerase and ATM kinase activity. a Human foreskin fibroblast
(HFF) cells were infected with HSV-1 (MOI 5) and cell lysates were prepared at various times post-infection. The lysates were immunoblotted and
probed with antibodies for total H2AX or its phosphorylated counterpart (γH2AX), with GAPDH as a loading control. b The transcription inhibitor
actinomycin D (A, 1 μg/ml) and the translation inhibitor cycloheximide (C, 100 μg/ml) were added to HFFs 1 h before HSV-1 infection or 1 μM
doxorubicin (Doxo) treatment. The DNA synthesis inhibitor phosphonoacetic acid (P, 400 μg/ml) was added at 1 h p.i. All compounds remained
in the media until lysis at 24 h p.i. c HFFs were infected with HSV-1 and/or HSV-2 with or without phosphonoacetic acid (PAA, 400 μg/ml). Cells
were lysed at 24 h p.i., immunoblotted, and probed for total H2AX, γH2AX, or VP16, with actin loading control. d Vero or HFF cells were either
mock-infected, infected with HSV-1 KOS strain (K), or infected with a mutant virus lacking UL30, either strain ΔS1 (Δ) or HP66 (H) at MOI 5. Cell
lysates were prepared at 16 h.p.i. and analyzed by immunoblot. e and f HFFs were infected with HSV-1 (panel e) or HSV-2 (panel f), immediately
overlaid with an ATM inhibitor (KU-55933, KU), an ATR inhibitor (VE-821, VE), or the two in combination (KV), and lysed at 24 h p.i. prior to
immunoblot analysis
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Curiously, however, PAA did inhibit H2AX phosphor-
ylation induced upon infection by HSV-2 (Fig. 1c). Thus,
DNA synthesis (and perhaps late protein expression) is
required to trigger γH2AX during infection by HSV-2
but not by HSV-1, an unexpected difference between
these two closely related viruses. Furthermore, co-
infection by HSV-1 and HSV-2 resulted in robust levels
of γH2AX that were not diminished by PAA, revealing
that HSV-2 infection does not elicit active repression of
H2AX phosphorylation. These observations indicate dis-
tinct differences in the DNA damage response pathway
involvement during HSV-1 and HSV-2 infection, despite
the many molecular similarities between the two viruses.
UL30 is required for H2AX phosphorylation during HSV-1
infection
The observation that addition of PAA did not diminish
H2AX phosphorylation during HSV-1 infection sug-
gested that viral DNA synthesis is not necessary for this
manifestation of the DNA damage response. As a further
test of this hypothesis, we predicted that infection by
HSV-1 mutants defective in viral DNA replication would
nonetheless induce γH2AX. We used two HSV-1 mutant
strains, HP66 and ΔS1 [21], which have substantial dele-
tions in the UL30 gene (encoding the viral DNA poly-
merase), to infect complementing Vero-PolB3 [21] or
non-complementing Vero or HFF cells at MOI 5. Sur-
prisingly, neither HP66 nor ΔS1 was able to induce sig-
nificant phosphorylation of H2AX in Vero or HFF cells
(Fig. 1d). However, the HP66 or ΔS1 strains did induce
γH2AX formation in the Vero-PolB3 cells (which ex-
press UL30 upon infection) regardless of PAA addition
(Fig. 1d). We conclude that expression of the wild-type
viral DNA polymerase protein, but not active viral DNA
synthesis, is required to induce H2AX phosphorylation
in cells infected by HSV-1.
ATM (but not ATR) is required for HSV H2AX
phosphorylation
To interrogate the role of phosphorylated H2AX in in-
fection of human fibroblasts by HSV-1 and HSV-2, we
inhibited ATM and ATR activity using three approaches:
chemical inhibitors of ATM or ATR kinase activity, siR-
NAs specific for ATM and ATR, and cell lines deficient
in either ATR or ATM.
To determine whether ATM, ATR, or both are required
for H2AX phosphorylation, we used two small-molecule
kinase inhibitors. KU-55933 inhibits ATM activity [25],
whereas VE-821 inhibits ATR activity [30, 32]. We in-
fected HFFs with HSV-1 or HSV-2 (MOI 5), applied the
kinase inhibitors, and harvested the cells at 24 h p.i. As
shown in Fig. 1e and f, KU-55933 repressed H2AX phos-
phorylation in cells infected by either HSV-1 or HSV-2,
but VE-821 did not, indicating that ATM, not ATR, was
responsible for H2AX phosphorylation.
We also performed comparable experiments with
CGK733, which reportedly inhibits both ATM and ATR
activity. Although the original report identifying
CGK733 as an ATM and ATR inhibitor [29] was
retracted [33], the inhibitory activity of CGK733 has
since been verified by independent laboratories [26–28].
CGK733 repressed γH2AX in cells infected by HSV-2
but, to our surprise, not in cells infected by HSV-1 (data
not shown). However, at the concentration of CGK733
required for repression of γH2AX (10 μM), the drug also
showed substantial cytotoxicity as assessed by CellTiter-
Glo reagent after 24 h (CC50 5.3 ± 1 μM) and a strong
caspase-3/7 response suggestive of apoptosis (ApoTox-
Glo assay) (data not shown). Although the differential
effect of CGK733 on HSV-1 and HSV-2 infection is in-
triguing, CGK733 was not used further because of the
cytotoxicity in HFF cells.
Neither ATM nor ATR activity is required for HSV-1 DNA
replication
Having established that HSV-induced H2AX phosphor-
ylation depends on ATM but not on ATR, we sought to
determine if inhibiting this phosphorylation impacts
HSV-1 and HSV-2 viral production. We measured the
amount of viral DNA in infected cells in the presence of
the ATM and ATR inhibitors, either alone or in combin-
ation. The relative concentrations of host DNA (18S
rRNA gene) and viral DNA (ICP0 gene) were measured
by qPCR and analyzed using the 2–ΔΔCt method. As
shown in Fig. 2a and b, KU-55933 moderately reduced
viral DNA production of both viruses, with slightly more
effect at low MOI. VE-821 had little effect on replication
regardless of virus or MOI, and the two compounds to-
gether did not reduce replication further than KU-55933
alone. Under these experimental conditions, KU-55933
repressed H2AX phosphorylation, but VE-821 did not
(see Fig. 1e and f). We conclude that neither ATM and
ATR activity, nor H2AX phosphorylation, is required for
viral DNA production in HFF cells.
ATM and ATR are dispensable for virus production
Although KU-55933 and VE-821 had little effect on viral
DNA replication, whether the inhibitors might have an
effect on other steps of virus production remained un-
answered. To address this, supernatants were harvested
from a representative experiment in Fig. 2a and infec-
tious virus yield was quantified by plaque assay (Fig. 2c).
Neither KU-55933 nor VE-821 alone diminished viral
yield and the two inhibitors in combination reduced
viral yield by less than twofold. Furthermore, neither
compound alone nor the combination affected either IE
gene (ICP4) or E gene (UL30) expression as demonstrated
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by RT-qPCR assays (Fig. 2d). These data indicate that both
ATM and ATR are ultimately dispensable for all steps of
HSV virus production in HFF cells.
siRNAs confirm that ATM and ATR are not required for
HSV infection
To further confirm that neither ATM nor ATR are re-
quired, HFF cells were transfected with siRNAs against
ATM or ATR, either alone or in combination, and were
then infected with HSV-1 or HSV-2 (MOI 5) approxi-
mately 72 h post-transfection. Total RNA and DNA
were harvested at 16 h p.i. and viral transcripts or ge-
nomes were quantified with qPCR. The efficacy and spe-
cificity of the siRNAs was evident in reduced transcript
and protein amounts for the targeted kinases (Fig. 3a
and b). However, disruption of either ATM or ATR ex-
pression had little effect on HSV-1 or HSV-2 DNA repli-
cation (Fig. 3c), further indicating that neither kinase is
vital for viral replication. When several siRNAs targeting
ATM and ATR were combined, we observed a modest
reduction of HSV-1 viral DNA (Fig. 3d), similar to that
of the chemical inhibitors. These data further confirm
that ATM and ATR activity, and thus H2AX phosphor-
ylation, are not required for HSV replication.
HSV-1 DNA replication is greatly reduced or delayed in
ATR- or ATM-deficient cells
A previous report indicated that HSV-1 requires ATM
for efficient replication based on evidence of reduced
viral replication in ATM−/− cells [11]. Since the data de-
scribed thus far in this report contradict that earlier con-
clusion, we decided to perform comparable experiments.
Two independent ATM−/− cell lines (GM01588A and
GM02052F, each expressing no ATM due to an early
stop codon) and one ATR-deficient cell line (Seckel syn-
drome, GM18366D, expressing low levels of ATR due to
alternate splicing), as well as a wildtype fibroblast line
(GM05757B), were procured from the Coriell Institute.
Cells from each of these lines were infected with HSV-1
to compare the production of viral DNA and infectious
progeny. Both of the ATM−/− cell lines produced much
less viral DNA and fewer infectious progeny at 24 h p.i.
than did wildtype fibroblasts, as measured by qPCR and
plaque assay (Fig. 4a). Both ATM−/− lines produced
somewhat higher titers at later times post-infection,
(Fig. 4a, right panel), although viral yield from the
GM02052F line remained 1 log lower than from wild-
type cells. A similar reduction in viral DNA and progeny
virus was observed in the ATR-deficient cells at 24 h p.i.
(Fig. 4b). We attempted to restore viral replication in
Fig. 2 ATM and ATR inhibitors moderately reduce HSV-1 DNA replication and virion production. a and b HFFs were infected with HSV-1 (panel a) or
HSV-2 (panel b) and immediately overlaid with ATM (KU-55933) or ATR (VE-821) kinase inhibitors alone or in combination. Total DNA was harvested at
24 h p.i. and viral DNA (vDNA) was quantified by qPCR. ICP0 levels were normalized to 18S controls and to DMSO-treated samples using the 2–ΔΔCt
method. Grey lines indicate the average of three experiments with infections at either low MOI (0.1; circles) or high MOI (5; squares). c Plaque assays
were performed on a representative experiment from panel (a). Each column represents the average and standard deviation of viral yield from biological
triplicates. d. HFFs were infected with HSV-1 at MOI 5 in the absence or presence of kinase inhibitors. Viral gene transcript levels were quantified at 6 h p.i.
by qPCR and normalized to 18S and DMSO levels (grey line denotes average of three experiments). Asterisks indicate results that are statistically significant
relative to DMSO control at p< 0.05
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ATR-deficient GM18366D cells by transfecting a plas-
mid expressing wild-type ATR protein, but a strong
interferon response to the transfected DNA led to re-
duced efficiency of infection (data not shown). Thus, we
cannot confidently conclude that the poor replication in
these cells is due solely to the ATR deficiency. These re-
sults seem to suggest that ATM and ATR are important
for viral replication, in agreement with the previous re-
port [11] but at odds with our results using kinase inhib-
itors and siRNAs.
To test whether this reduction of viral DNA replica-
tion in ATR-deficient cells was due to inefficient infec-
tion or trafficking to the nucleus, we quantified the
amount of viral DNA in the nucleus very early in infec-
tion. The fibroblast control and ATR-deficient cells were
infected with HSV-1 (MOI 5), and at 2 h p.i. the cells
were collected. Nuclei were isolated via gradient centri-
fugation [31] and qPCR was used to quantify viral ge-
nomes present in the nuclear fraction. Viral DNA was
present at comparable levels in control and deficient nu-
clei (Additional file 1: Figure S1), indicating the observed
viral DNA reduction is not due to attenuated entry of
viral DNA to the nucleus. Since these cells likely have
adapted mechanisms to overcome the loss of ATM or
ATR, it is possible that the altered cellular pathways are
not adequate to support efficient HSV-1 replication.
Together, these data suggest that the dependence of
HSV DNA replication on ATM and ATR is cell-type-
specific.
Discussion
A number of viruses make use of the cellular DNA repair
machinery to promote successful infection. One of the
first proteins to be activated upon DNA damage is H2AX
[34]. Phosphorylated H2AX (γH2AX) spreads over chro-
matin flanking the DNA damage site [35] and acts as a
signal for recruiting other DNA damage response proteins
[36]. Others have noted that HSV-1infection is sufficient
to induce γH2AX formation [6, 7]. We too observed that
HSV-1 infection induced γH2AX formation at 4 h p.i. and
that the phosphorylation increased over time. We found
that de novo protein synthesis is required for H2AX phos-
phorylation but neither viral replication nor late viral pro-
tein expression is required for this phosphorylation event.
Thus, induction of H2AX phosphorylation is not triggered
merely by the presence of viral DNA in the infected cell
nor by replication of viral DNA, but by expression of
some viral or cellular protein following infection.
Fig. 3 ATM and ATR siRNAs moderately reduce viral DNA production. HFFs were transfected with siRNAs targeting ATM or ATR. At 72 h post-
transfection, cells were infected with HSV-1 or HSV-2 (MOI 5) and harvested at 16 h p.i. a ATM and ATR transcript levels in siRNA-transfected cells
were quantified using qPCR, normalized to 18S and control siRNA (Allstar, AS) by the 2–ΔΔCt method. b Protein lysates of siRNA-transfected cells
were immunoblotted and probed with antibodies specific for ATM or ATR. c Viral DNA levels (vDNA) were quantified by qPCR with ICP0 primers,
normalized to 18S rDNA levels and Allstar control siRNA. d HSV-1 DNA levels in HFFs transfected with pooled ATM and/or ATR siRNAs were quantified
by qPCR. In panels (a), (c), and (d), grey lines indicate the average of three experiments. Asterisks indicate statistical significance relative to Allstar control
at p < 0.05
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Curiously, although viral DNA replication is not re-
quired to induce γH2AX, expression of the viral DNA
polymerase is required. Infection by two different viral
mutants, HP66 and ΔS1 (each bearing substantial dele-
tions of the UL30 open reading frame), failed to induce
γH2AX. It is puzzling that expression of the viral DNA
replication enzyme, but not DNA replication itself, is re-
quired for the formation of γH2AX during HSV-1 infec-
tion. We infer that H2AX phosphorylation is triggered
by an event that occurs after UL30 expression but before
HSV-1 DNA replication, perhaps during establishment
of replication centers. This notion agrees with work by
Wilkinson and Weller [7, 15] showing that γH2AX accu-
mulates around the viral replication compartments.
Combined with the observation that ATM is solely re-
quired for H2AX phosphorylation, we speculate that the
viral DNA polymerase could be involved in the recruit-
ment of ATM to replication compartments, although
further study would be needed to establish this point.
A second surprising observation was that H2AX phos-
phorylation during HSV-2 infection was blocked by the
viral DNA replication inhibitor PAA, in stark contrast to
HSV-1 infection. We presume that expression of UL30
is also required for H2AX phosphorylation during HSV-
2 infection because viral DNA synthesis is required, but
HSV-2 UL30 mutants are not readily available to test
that presumption directly. We therefore infer the DDR
pathway is activated differently in HSV-1 and HSV-2
infections; more work will be needed to better under-
stand the mechanistic differences between these two
closely related viruses.
Activation of ATM and at least some of its down-
stream targets by both HSV-1 and HSV-2 has been
shown previously [11, 14, 15, 37, 38]. Our results indi-
cate that during HSV-1 or HSV-2 infection, H2AX was
phosphorylated solely by ATM. Furthermore, inhibition
of ATM has been shown to decrease HSV-1 viral DNA
replication in certain contexts [11, 19]. However, in our
experiments, chemical inhibition of ATM and/or ATR
or disruption of ATM and ATR expression by siRNAs
had little or no effect on HSV-1 and HSV-2 DNA repli-
cation and virus production. Therefore, although ATM
signaling is activated by HSV-1 infection, ATM is not
vital for efficient HSV replication in HFF cells, and thus
γH2AX formation is likely an incidental signal during in-
fection. Since ATM is activated and γH2AX is formed, it
seems reasonable to consider whether ATR is also acti-
vated. Others have shown that viral proteins prevent the
phosphorylation of typical ATR targets during HSV-1 in-
fection, and shRNA disruption of ATR alone has little
effect on viral yield [11, 13–17, 39]. In our hands as well,
ATR activity does not contribute substantially to phos-
phorylation of H2AX during HSV infection, and ATR
activity is not required for effective viral replication.
Moreover, HSV-1 was insufficient to activate Chk-1 and
thus downstream ATR activation (data not shown).
Fig. 4 HSV-1 replication and virion production are reduced in both ATM−/− and ATR-deficient cell lines. ATM−/− cells (GM01588A and GM02052F),
ATR-deficient (GM18366D) cells, or normal human fibroblasts (GM05757B) were infected with HSV-1 (MOI 5). a. Infection of ATM−/− cells. b. Infection of
ATR-deficient cells. Left panels: At 24 h p.i., total DNA was harvested from cells and supernatant. Viral DNA (vDNA) was quantified using ICP0 primers
and normalized to 18S rDNA and GM05757B values. Grey lines indicate mean of triplicate experiments. Right panels: Plaque assays were performed
using supernatants collected at various times from infected cells. Bars represent the average and standard deviation of biological triplicates. Asterisks
indicate statistical significance relative to wildtype fibroblasts at p < 0.05
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ATM and the γH2AX response have also been studied
in the context of infection by other herpesviruses. Con-
flicting reports suggest that ATM is required for max-
imum yield of human cytomegalovirus and for maturation
of replication compartments in HEL fibroblasts [40], yet
ATM− cells had only a 1 log reduction in viral yield as
compared to HFF cells [41]. The literature is likewise di-
vided over the role of ATM kinase activity during EBV in-
fection; one report [42] concludes that ATM is important
for efficient EBV lytic replication in Akata BX1 latent cells
but another report [43] indicates that ATM is dispensable
for EBV lytic replication in Tet-BZLF1/B95-8 cells. A
comprehensive report of various stimuli of EBV in various
cell lines indicates that strict dependence on ATM is
stimulus-specific; ATM was vital for early steps in reacti-
vation but not for viral DNA replication per se [44]. Fur-
thermore, murine herpesvirus 68 required ATM and
γH2AX in primary mouse macrophages only at low MOI,
but neither are required for growth in MEFs regardless of
MOI [45, 46]. Karposi sarcoma virus depends on ATM, as
shown by reduced establishment and latency of KSHV in
the absence of ATM [47, 48]. However, VZV does not
seem to depend similarly on ATM since it displayed near
normal production in GM02530 ATM− cells [49]. The
varying reports for CMV, EBV and HV68 together with
the data in this report indicate that cell type is a key factor
in virus reliance on DNA damage pathways during herpes
virus infection.
In contrast with our results using chemical inhibitors
and siRNAs targeting ATM and ATR, but consistent
with reports from others [11, 19], we observed a reduc-
tion of both viral DNA replication and viral yield upon
infecting either ATM−/− cell lines or an ATR-deficient
cell line at 24 h. A longer timecourse in the ATM− cells
did reveal higher yield of virus at later times, with one
line eventually reaching levels comparable to wildtype
cells. Our observations support those of Lilley et al. [11],
who observed that the yields of HSV-1 from three ataxia
telangiectasia lines were reduced by two orders of mag-
nitude at 24 h p.i., although two lines did recover to near
wt yield at 36 h p.i. In contrast, Yamamoto et al. [49]
showed that both VZV and HSV-2 produced near-
normal titers throughout the entire 36 h of infection in
GM02530 cells. This discrepancy is echoed by Zavala et al.
[50] in their investigation of disparate HCMV production
in mutant cells. Although they observed that distinct
strains of HCMV yielded different titers in individual
ATM− cell lines, they determined that ATM was not
necessary for normal titers in fibroblasts. This aligns
well with the data we present here for HSV-1. We
surmise that the ATM- and ATR-deficient cells may
have developed mechanisms to compensate for the
lack of DNA damage kinases that are not compatible
with efficient HSV-1 replication. Clearly the two ATM
− cell lines tested here have adapted in different ways,
since they differed in virus production at late times in
infection despite having identical mutations in the
ATM gene. It is conceivable that the non-homologous end
joining pathway, known to be antiviral [18], is more
active in these cells leading to decreased or delayed
replication. Additionally, fibroblasts and keratinocytes
have different efficiencies in supporting replication of
UV-damaged HSV, indicating that DDR pathway acti-
vation varies significantly between cell types [51].
Inhibition of ATM, and perhaps even of ATR, may be
more severe in oral keratinocytes than HFFs because
their DNA damage pathways mobilize differently in
response to HSV.
The HSV-1 genome is known to contain nicks and
single-strand gaps of various sizes that affect infectivity
[52]. Moreover, complex replication intermediates have
been observed indicative of recombination events [53].
Additionally, the linear genome may circularize prior to
lytic replication, though recent reports have differed on
this point [54, 55]. Given the role of γH2AX and ATM in
homologous recombination, it is logical to hypothesize
that these proteins participate in such recombination
events during HSV-1 and HSV-2 infection. However, since
ATM is dispensable for infection of HFFs, the viral DNA
must recombine by means other than canonical ATM-
dependent homologous recombination, perhaps through
proteins that can complement ATM’s function. The
additional disparity between HSV-1 and HSV-2 in γH2AX
induction suggests differences in recombination mecha-
nisms during infections by these two closely related
viruses. Most DNA replication studies have been done
using HSV-1 and inferred for HSV-2, but perhaps
these viruses replicate more differently than previously
supposed. It would be interesting to determine the
circularization and recombination rate of both HSV-1
and HSV-2 in the absence of cellular DDR proteins,
especially ATM.
Conclusion
In summary, we have shown that H2AX phosphorylation
is performed by ATM during HSV-1 and HSV-2 infec-
tion. This event during HSV-1 infection is dependent on
the presence of the viral DNA polymerase (but not viral
DNA synthesis), but in HSV-2 infection it is replication-
dependent. Furthermore, although ATM is responsible
for infection-induced H2AX phosphorylation, neither
ATM nor the closely related ATR kinase is strictly re-
quired for efficient HSV production. HSV-1 and HSV-2
replication is known to require recombination events
that result in nicked and gapped products. It is likely
that this DNA damage signal is a natural cellular
response to early steps of HSV replication and is respon-
sible for recruiting ATM and ATR to replication
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compartments but does not enhance or lessen replication
in HFF cells. We conclude that γH2AX is a chromatin
mark indicative of a cell-type-specific host response that is
not essential for HSV-1 or HSV-2 infection.
Additional file
Additional file 1: Figure S1. HSV-1 DNA enters nuclei of ATR-deficient
cells at comparable levels to that of WT fibroblasts. WT fibroblasts
(GM05757B) or AT-deficient fibroblasts (GM18366D) were infected with
HSV-1 (MOI 5) and trypsinized at 2 h p.i. Nuclei were isolated via gradient
centrifugation and viral DNA was quantified with qPCR. ATR-deficient cells
were compared to WT fibroblasts using the 2–ΔΔCt method. Grey bars repre-
sent the average of three experiments. (PDF 65 kb)
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